Stock analysts at StockNews.com assumed coverage on shares of China Jo-Jo Drugstores (NASDAQ:CJJD – Get Free Report) in a research report issued on Wednesday. The firm set a “sell” rating on the stock.
China Jo-Jo Drugstores Stock Performance
Shares of NASDAQ CJJD opened at $0.18 on Wednesday. China Jo-Jo Drugstores has a 12 month low of $0.17 and a 12 month high of $9.65. The firm has a fifty day simple moving average of $0.20 and a two-hundred day simple moving average of $0.25.
Institutional Inflows and Outflows
Institutional investors have recently added to or reduced their stakes in the stock. Virtu Financial LLC raised its holdings in China Jo-Jo Drugstores by 1,004.3% in the 2nd quarter. Virtu Financial LLC now owns 125,689 shares of the company’s stock worth $50,000 after purchasing an additional 114,307 shares in the last quarter. Acadian Asset Management LLC bought a new position in shares of China Jo-Jo Drugstores in the 2nd quarter worth about $61,000. Finally, Jane Street Group LLC bought a new position in shares of China Jo-Jo Drugstores in the 4th quarter worth about $112,000. 3.63% of the stock is currently owned by institutional investors.
China Jo-Jo Drugstores Company Profile
China Jo-Jo Drugstores, Inc, together with its subsidiaries, operates as a retailer and distributor of pharmaceutical and other healthcare products in the People's Republic of China. The company operates through four segments: Retail Drugstores, Online Pharmacy, Drug Wholesale, and Herb Farming.
- Five stocks we like better than China Jo-Jo Drugstores
- The 3 Best Fintech Stocks to Buy Now
- 5 best stocks to buy in a bear market
- How to Invest in EV Charging Stations
- 2 REIT stocks set to surge due to red hot data center demand
- Growth Stocks: What They Are, Examples and How to Invest
- How and when to use LEAPS stock options
Receive News & Ratings for China Jo-Jo Drugstores Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Jo-Jo Drugstores and related companies with MarketBeat.com's FREE daily email newsletter.